GR82238B - - Google Patents

Info

Publication number
GR82238B
GR82238B GR75167A GR840175167A GR82238B GR 82238 B GR82238 B GR 82238B GR 75167 A GR75167 A GR 75167A GR 840175167 A GR840175167 A GR 840175167A GR 82238 B GR82238 B GR 82238B
Authority
GR
Greece
Application number
GR75167A
Other languages
Greek (el)
Inventor
Hans-Dieter Dr Dell
Bernhard Dr Pelster
Reinhold Kraus
Detlef Dr Schiestedt
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of GR82238B publication Critical patent/GR82238B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GR75167A 1983-07-05 1984-07-03 GR82238B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833324193 DE3324193A1 (de) 1983-07-05 1983-07-05 Depot-antiphlogistika

Publications (1)

Publication Number Publication Date
GR82238B true GR82238B (en:Method) 1984-12-13

Family

ID=6203193

Family Applications (1)

Application Number Title Priority Date Filing Date
GR75167A GR82238B (en:Method) 1983-07-05 1984-07-03

Country Status (8)

Country Link
US (1) US4614741A (en:Method)
EP (1) EP0130514A3 (en:Method)
JP (1) JPS6036409A (en:Method)
KR (1) KR850000978A (en:Method)
DE (1) DE3324193A1 (en:Method)
DK (1) DK328484A (en:Method)
GR (1) GR82238B (en:Method)
PT (1) PT78838B (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
CH673395A5 (en:Method) * 1987-01-30 1990-03-15 Ciba Geigy Ag
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
IT1318654B1 (it) * 2000-07-28 2003-08-27 Prodotti Antibiotici Spa Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
FR3000392B1 (fr) * 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
KR101817028B1 (ko) 2013-12-16 2018-01-09 조에티스 서비시즈 엘엘씨 지속성 케토프로펜 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
NL175882C (nl) * 1977-03-28 Procter & Gamble Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
US4325949A (en) 1980-02-15 1982-04-20 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen

Also Published As

Publication number Publication date
DE3324193A1 (de) 1985-01-17
KR850000978A (ko) 1985-03-14
JPS6036409A (ja) 1985-02-25
DK328484A (da) 1985-01-06
EP0130514A3 (de) 1986-08-13
EP0130514A2 (de) 1985-01-09
PT78838A (en) 1984-08-01
US4614741A (en) 1986-09-30
PT78838B (en) 1986-06-02
DK328484D0 (da) 1984-07-04

Similar Documents

Publication Publication Date Title
BR8407173A (en:Method)
FR2547627B1 (en:Method)
GR82004B (en:Method)
GR82316B (en:Method)
FR2542895B3 (en:Method)
GR82238B (en:Method)
GR81698B (en:Method)
AT378328B (en:Method)
FR2540943B1 (en:Method)
FR2539761B1 (en:Method)
FR2542627B3 (en:Method)
DE3467218D1 (en:Method)
FR2540897B1 (en:Method)
GR72900B (en:Method)
AU1299683A (en:Method)
BR6301293U (en:Method)
AU9008182A (en:Method)
GR72097B (en:Method)
GR71826B (en:Method)
AU1412583A (en:Method)
BG45371A1 (en:Method)
BG44648A1 (en:Method)
BG44566A1 (en:Method)
BG44587A1 (en:Method)
BG44586A1 (en:Method)